Immediate Impact
62 standout
Citing Papers
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Works of Julie Bykowski being referenced
A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma
2022
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Julie Bykowski | 167 | 234 | 151 | 223 | 168 | 43 | 829 | |
| A. L. Pahor | 121 | 304 | 139 | 155 | 187 | 51 | 756 | |
| Dennis R. Maceri | 175 | 439 | 165 | 208 | 187 | 47 | 848 | |
| Joseph M. Aulino | 170 | 288 | 56 | 114 | 95 | 45 | 691 | |
| Curtis Offiah | 211 | 333 | 102 | 109 | 96 | 31 | 922 | |
| Edward J. Escott | 269 | 300 | 135 | 74 | 105 | 42 | 886 | |
| Ho-Fai Wong | 164 | 225 | 201 | 123 | 194 | 28 | 667 | |
| Niranjan Bhandare | 73 | 185 | 273 | 210 | 222 | 31 | 908 | |
| Rohini N. Nadgir | 143 | 304 | 107 | 68 | 142 | 41 | 791 | |
| Moon‐Sing Lee | 44 | 214 | 229 | 214 | 202 | 61 | 907 | |
| Shy‐Chyi Chin | 227 | 368 | 237 | 94 | 203 | 71 | 898 |
All Works
Login with ORCID to disown or claim papers
Loading papers...